YM155 induces EGFR suppression in pancreatic cancer cells

Young Soon Na, Soo Jin Yang, Seung Mi Kim, Kyung Ah Jung, Jai Hee Moon, Jae Sik Shin, Dok Hyun Yoon, Yong Sang Hong, Min Hee Ryu, Jae Lyun Lee, Jung Shin Lee, Tae Won Kim

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

YM155, which inhibits the anti-apoptotic protein survivin, is known to exert anti-tumor effects in various cancers, including prostate and lung cancer. However, there are few reports describing the inhibitory effect of YM155 on human pancreatic cancers that highly express survivin. Here, we tested the effects of YM155 on a variety of cancer cell lines, including pancreatic cancer cells. We found that YM155 exerts an anti-proliferative effect in pancreatic cancer cells, inducing cell death through suppression of XIAP (X-linked inhibitor of apoptosis) as well as survivin without affecting the anti-apoptotic proteins Bcl-xL or Mcl-1. YM155 also inhibited tumor growth in vivo, reducing the size of pancreatic cancer cell line MIAPaCa-2 xenografts by 77.1% on day 31. Western blot analyses further showed that YM155 downregulated phosphoinoside 3-kinase (PI3K) expression and reduced the levels of phosphorylated (activated) extracellular signal-regulated kinase (ERK) and STAT3 (signal transducer and activator of transcription 3) in PANC-1 cells. Interestingly, we also found that YM155 downregulated the epidermal growth factor receptor (EGFR) in various cancer cell lines and induced the EGFR phosphorylation and ubiquitination of EGFR in PANC-1 cells. YM155 also modestly promoted the ubiquitination of survivin and XIAP. Therefore, YM155 acts through modulation of EGFR and survivin expression to subsequently reduce survival. We suggest that YM155 has potential as a therapeutic agent in the treatment of pancreatic cancer.

Original languageEnglish (US)
Article numbere38625
JournalPloS one
Volume7
Issue number6
DOIs
StatePublished - Jun 18 2012

Fingerprint Dive into the research topics of 'YM155 induces EGFR suppression in pancreatic cancer cells'. Together they form a unique fingerprint.

Cite this